Logo Logo

A Dose of Managed Care: Controlling Drug Spending in Medicaid

Abstract

Effectively designed market mechanisms may reduce growth in health care spending. In this paper, we study the impact of privatizing the delivery of Medicaid benefits on drug prices and utilization. Exploiting granular data, we find that drug spending would fall by 22.4 percent if the drug benefit was fully administered by Medicaid Managed Care Organizations (MCOs), largely through lower point-of-sale prices and greater generic usage. The effects are driven by MCOs’ ability to design drug benefits and steer consumers toward lower cost drugs and pharmacies. By contrast, MCOs do not appear to skimp on performance by reducing overall drug consumption.

Type

Working Paper

Author(s)

David Dranove, Christopher Ody, Amanda Starc

Date Published

2018

Citations

Dranove, David, Christopher Ody, and Amanda Starc. 2018. A Dose of Managed Care: Controlling Drug Spending in Medicaid.

KELLOGG INSIGHT

Explore leading research and ideas

Find articles, podcast episodes, and videos that spark ideas in lifelong learners, and inspire those looking to advance in their careers.
learn more

COURSE CATALOG

Review Courses & Schedules

Access information about specific courses and their schedules by viewing the interactive course scheduler tool.
LEARN MORE

DEGREE PROGRAMS

Discover the path to your goals

Whether you choose our Full-Time, Part-Time or Executive MBA program, you’ll enjoy the same unparalleled education, exceptional faculty and distinctive culture.
learn more